• Western blot analysis of Jurkat cells using DCAMKL3 Polyclonal Antibody
  • Immunohistochemistry analysis of paraffin-embedded human brain, using DCLK3 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using DCAMKL3 Polyclonal Antibody

Anti-DCLK3 antibody (291-340 aa) (STJ92664)

SKU:
STJ92664

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Serine/threonine-protein kinase DCLK3 (291-340 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:5000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: DCLK3
Gene ID: 85443
Uniprot ID: DCLK3_HUMAN
Immunogen Region: 291-340 aa
Specificity: DCAMKL3 Polyclonal Antibody detects endogenous levels of DCAMKL3 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human DCLK3 at the amino acid range 291-340
Cellular Localisation Cytoplasm
Nucleus
Alternative Antibody Names Anti-Serine/Threonine-Protein Kinase Dclk3 antibody
Anti-Doublecortin Domain-Containing Protein 3c antibody
Anti-Doublecortin-Like And Cam Kinase-Like 3 antibody
Anti-Doublecortin-Like Kinase 3 antibody
Anti-DCLK3 antibody
Anti-DCAMKL3 antibody
Anti-DCDC3C antibody
Anti-KIAA1765 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance